What is Mirvaso?
Mirvaso is a topical gel developed specifically to treat persistent skin redness caused by rosacea. It contains the active ingredient brimonidine, which is a type of medicine called an alpha agonist. Alpha agonists cause, among other things, the blood vessels to narrow.
What is it used for?
Mirvaso is used to treat rosacea, a skin condition where redness appears on the cheeks, chin, nose and/or forehead due to dilated blood vessels. Mirvaso works by constricting the dilated blood vessels to reduce facial redness.
How to use Mirvaso
Mirvaso topical gel should be applied thinly to the skin on the face. A ‘pea-sized’ dose is enough for the entire face. Always apply the gel to clean skin. Allow the skin to dry before applying other care products or make-up. Do not use this medicine on other parts of the body and avoid contact with lips, eyelids and mucous membranes (eyes, mouth, nasal cavity). Wash your hands thoroughly after applying the gel. Read package leaflet before use.
Unless otherwise prescribed by your doctor, the general recommended dose for adults is:
- a small amount of Mirvaso gel applied once daily to the affected areas in the face.
Mirvaso may cause side effects. The most commonly noted side effects include:
- Skin irritations (burning sensation, tingling, pain or itching) in the areas where the gel was applied;
- Facial flushing;
When not to use Mirvaso
Mirvaso topical gel is not suitable for everyone. You should not use Mirvaso if:
- you are allergic to brimonidine or any other ingredient in Mirvaso;
- you are taking certain medicines used for depression or Parkinson’s disease.
Mirvaso should only be used with your doctor’s approval if you are pregnant or breastfeeding.
Mirvaso does not affect your reaction time or impair your ability to drive safely.
Consuming alcohol regularly could affect your treatment with this medicine. It is therefore advisable to reduce or stop alcohol consumption while taking Mirvaso.